What are the risks of investing in OMER?
O
What are the risks of investing in OMER?
🦉
Omeros Corporation (OMER)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOGregory A. Demopulos
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and...
Key Executives
| Name | Title |
|---|---|
| Andreas Grauer | Vice President & Chief Medical Officer |
| Catherine A. Melfi | Chief Regulatory Officer & Vice President of Regulatory Affairs and Quality Systems |
| David J. Borges | Vice President of Finance, Chief Accounting Officer & Treasurer |
| David W. Ghesquiere | Vice President & Chief Business Development Officer |
| George A. Gaitanaris | Chief Scientific Officer & Vice President of Science |
| Gregory A. Demopulos | Co-Founder, Chairman, Chief Executive Officer & President |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A